U.S. employers eye cutting wasteful drugs worth $6 billion | Medxoom Skip to main content

U.S. employers eye cutting wasteful drugs worth $6 billion

Sep 2020
Emily Paffhausen

Medxoom helps to optimize consumer healthcare by unifying the health benefits experience. Prices vary in every city for the same medical procedure, even in a pandemic. Medxoom can help healthplan members know the cost and quality before they seek medical services.

Now there is a new “guidebook produced by the Pacific Business Group on Health and researchers from Johns Hopkins University that identifies 49 medications with less expensive alternatives that could be cut from the lists of drugs covered by employers.”

Read Now

Sign up for our newsletter to stay up to date with our app.

  • This field is for validation purposes and should be left unchanged.